Vietnam Orders Drug Makers To Focus On H1N1 Flu, Diarrhea Treatments
This article was originally published in PharmAsia News
Vietnam authorities are instructing drug makers and retailers to step up their attention on making sure the country has enough drugs to treat both the A/H1N1 flu virus and acute diarrhea. The Vietnam Drug Administration also told those companies and health departments around the country to keep their attention on disinfectants as well. The pharmaceuticals and importers need to have enough drugs to prevent and treat an outbreak of any of those diseases, the agency's head said. (Click here for more
You may also be interested in...
Demand for tele-diagnostic tools has reached unprecedented levels during COVID-19, said Kees Wesdrop, Royal Philips’ chief business leader of precision diagnosis.
Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue
Former acting Commissioner Josh Sharfstein argues that while agency officials have done a commendable job in overall communication on COVID vaccine development, more information is needed on the clinical holds.
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.